How long do acute coronary syndrome patients wait for reperfusion, diagnostic coronary angiography and surgical revascularisation?

New Zealand Medical Journal

Volumn 126, Issue 1376, 2013, Pages

  Voss, Jamie ^a   Martin, Andrew ^b   Caldwell, Imogen ^b   Lee, Mildred ^c   Kerr, Andrew J ^a  

^a MIDDLEMORE HOSPITAL   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c Data analyst   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY CARE UNIT; CORONARY REPERFUSION; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; ETHNICITY; FEMALE; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT DURATION; UNSTABLE ANGINA PECTORIS; DELAYED DIAGNOSIS; HEART INFARCTION; HOSPITAL READMISSION; LENGTH OF STAY; MECHANICAL THROMBECTOMY; MEDICAL AUDIT; MIDDLE AGED; NEW ZEALAND; PATIENT TRANSPORT; PRACTICE GUIDELINE; RADIOGRAPHY; RISK; STATISTICS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; VERY ELDERLY;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DELAYED DIAGNOSIS; FEMALE; GUIDELINE ADHERENCE; HUMANS; LENGTH OF STAY; MALE; MECHANICAL THROMBOLYSIS; MEDICAL AUDIT; MIDDLE AGED; MYOCARDIAL INFARCTION; NEW ZEALAND; ODDS RATIO; PATIENT READMISSION; PATIENT TRANSFER; PRACTICE GUIDELINES AS TOPIC; TIME FACTORS;

EID: 84878986525     PISSN: 00288446     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Garafalo D, Grey C, Lee M et al. Pre-hospital delay in acute coronary syndromes: PREDICT CVD- 18. NZ Med J. 2012 Jan 20;125(1348):12-22.
2. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004 Mar 16;109(10):1223-1225. Epub 2004 Mar 8.
3. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994 Feb 5;343(8893):311-22.
4. Katritis DG, Siontis GC, Kastrati A et al. Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes. Eur Heart J. 2011 Jan:32(1):32-40. Epub 2010 Aug 13.
5. Mehta SR, Granger CB, Boden WE et al et al; TIMACS Investigators. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009 May 21;360 (21):2165-75.
6. Taggart DP, Boyle R, de Belder MA, Fox KA. The 2010 ESC/EACTS guidelines on myocardial revascularisation. Heart. 2011 Mar;97(6):445-446. Epub 2010 Dec 14.
7. Non ST-Elevation Acute Coronary Syndrome Guidelines Group and the New Zealand Branch of the Cardiac Society of Australia and New Zealand. New Zealand 2012 guidelines for the management of non ST-elevation acute coronary syndromes. NZ Med J. 2012 Jun 29;125(1357):122.
8. Antman EM, Anbe DT, Armstrong PW et al. ACC/AHA guidelines for the management of patients with St-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practise Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004 Aug 31;110(9):e82-292.
9. ST-Elevation Myocardial Infarction Guidelines Group; New Zealand Branch of the Cardiac Society of Australia and New Zealand. ST-elevation myocardial infarction: New Zealand management guidelines. NZ Med J. 2005 Oct 7;118(1223):U1679.
10. Kerr AJ, Looi JL, Garafalo D et al. Acute Predict: A clinician-led cardiovascular quality improvement project (Predict CVD 12). Heart Lung Circ. 2010 May-Jun;19(5-6):378-83. Epub 2010 Apr 14.
11. ISIS-2 (Second International Study of Infarct Survival). Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988 Aug 13;2(8607):349-60.
12. Baigent C, Collins R, Appleby P et al; The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. BMJ. 1998 May 2;316(7141):1337-43.
13. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003 Jan 4;361(9351):13-20.
14. Ellis C, Devlin G, Elliot J et al; New Zealand Acute Coronary Syndrome (NZACS) Audit Group. ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: results of the second comprehensive national audit of ACS patients. NZ Med J. 2010 Jul 30;123(1319):44-60.
15. Task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of European Society of Cardiology, Bassand JP, Hamm CW, Ardissino D et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007 Jul;28(13):1598-660. Epub 2007 Jun 14.